ACE2 and viral infectious disease: To such an aim, human endothelial umbilical vein cells (HUVECs) were used, as they have been widely documented to express very low levels of the SARS‐CoV‐2 receptor ACE2 and the protease TMPRSS2, which restrains their capacity for productive viral infection [33–36].